LOADING
Comparing Johnson & Johnson (JNJ) and Salesforce Inc (CRM) across the Health Care and Technology sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | JNJ | CRM |
|---|---|---|
| Price | $255.82 | $180.71 |
| Change Today | -3.66% | -4.07% |
| Market Cap | $639.9B | $154.3B |
| P/E Ratio | 30.9 | 21.9 |
| Forward P/E | 22.9 | 12.8 |
| PEG Ratio | 4.40 | 0.72 |
| EPS | $8.58 | $8.62 |
| Revenue Growth (YoY) | 6.6% | 13.3% |
| Profit Margin | 21.5% | 18.7% |
| Return on Equity | 25.7% | 16.9% |
| Dividend Yield | 1.96% | 0.93% |
| Beta | 0.23 | 1.18 |
| 52-Week High | $274.90 | $267.75 |
| 52-Week Low | $160.76 | $146.32 |
| Volume | 8.2M | 12.2M |
Johnson & Johnson is the larger company by market capitalization. Salesforce Inc trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. Johnson & Johnson offers a higher dividend yield for income investors. Johnson & Johnson has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.